An Open-Label, Parallel-Group Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Ocrelizumab in Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-507313-94-00